This is the part that many are misssing. NT219 ( $ktov ) and Keytruda ( $mrk ) TOGETHER pummeled esophagus cancer in their research. 

To me, this screams collaboration or buyout (4.5 billion 💵 says this is possible).

Would love to hear what people think is worst case scenario? https://t.co/AzrUJYYDhX